It inhibits the production of multiple pro-inflammatory cytokines, including IFNγ, TNF-α, IL-5, IL-1β, etc.50, and is only marginally less prevalent in T1D patients studied at the time of diagnosis than in healthy subjects45. This evidence concerns the gene IL5 and type 1 diabetes mellitus.